Publication for PSMB8 and NMI
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | PSMB8 | proteasome 20S subunit beta 8 | 5696 | [link] | ||
| hsa | NMI | N-myc and STAT interactor | 9111 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 26474164 | 0.98 | NMI, IFI35, PSMB9, GBP1, PSMB8, PSMB10) have greater fold changes that range from 3.5- to >76,000-fold increases in DBA patients relative to healthy donors. |
| 29463848 | 0.96 | PSMB8, PSME1, IRF-1, SAMD9L, DTX3L, IFI35, NMI, TRIM38, and TRIM22, as light-emitting fusion proteins for LIPS autoantibody testing. |
| 0.96 | PSMB8, PSME1, IRF1, SAMD9L, DTX3L, IFI35, and NMI, exhibited no significant autoantigenicity (i.e. less than 1% sensitivity) in the SS subjects compared to the healthy volunteers (data not shown). |
The preparation time of this page was 0.0 [sec].
